CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson

About this episode

Dr Paul G Richardson discusses the function and future role of CELMoDs in treating multiple myeloma.

Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma. CME information and select publications here .

People in this episode

Host: Dr. Neil Love

Guest: Dr Paul G Richardson

Topics covered

• CELMoDs
• Multiple Myeloma
• Cancer Treatment
• Medical Research
• Pharmaceuticals

Keywords

• CELMoDs
• Multiple Myeloma
• Cancer
• Treatment
• Dana-Farber
• Research
• Pharmaceuticals

Mentioned in this episode

Organizations: Dana-Farber Cancer Institute

Places: Boston, Massachusetts

More episodes of Oncology Today with Dr Neil Love

• Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting · June 12, 2026 · 1h 29m
• HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy · June 11, 2026 · 58 min
• Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances · June 8, 2026 · 59 min
• Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays · June 5, 2026 · 23 min
• Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer · June 3, 2026 · 1h 31m
• Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper · June 2, 2026 · 23 min